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Catatonia during Deep Brain Stimulator
Implantation Complicated by Intracranial
Hemorrhage
Catatonia is a syndrome of motor dysregulation character-
ized by fluctuating stupor, mutism, negativism, catalepsy, auto-
matic obedience, and stereotypy.1 Other motor signs include
gegenhalten, mitgehen, waxy flexibility, echophenomena, and
ambitendency. The diagnosis requires two to four features.2
The pathophysiology of catatonia remains unclear but may
involve dysfunction of frontal circuitry and motor regulatory
brain areas. Catatonia is most closely associated with mood
disorders but also results from medications (e.g., dopamine
blockers and serotonergic agents), metabolic derangement,
seizures, or focal structural brain lesions.2 We present a
patient with Parkinson’s disease (PD) who developed catato-
nia during deep brain stimulation (DBS) surgery complicated
by intracranial hemorrhage.
The patient was a 60-year-old right-handed woman with
levodopa-responsive PD for 12 years. Prior to surgery, she
was taking levodopa 800 mg, entacapone 800 mg, and ropinirole
8 mg daily but experienced debilitating motor fluctuations, ab-
rupt ‘‘off’’ periods, and dyskinesias, despite adjustments to her
medication regimen. She had a history of nonmelancholic
depression treated with citalopram 20 mg daily. During presur-
gical evaluation, she had no dementia on neuropsychological
testing or evidence of an active mood disorder. Off-on Unified
Parkinson’s Disease Rating Scale (UPDRS) testing demon-
strated at least a 32% improvement to her standard morning
levodopa dose. She was deemed an appropriate DBS candidate
and underwent surgical placement of DBS electrodes into each
subthalamic nucleus using microelectrode recordings. The sur-
gery was conducted in the off medication state, over 12 hours
after her last dose of PD medication. Mild hypertension during
the procedure was controlled with low doses of metoprolol.
Before DBS electrode placement, the patient spoke only
when asked questions or to complain of intermittent left arm
pain. During right electrode placement, she gradually devel-
oped dystonic flexion posturing of the left arm and intermit-
tent flexion of the right arm and left leg. When asked ques-
tions or given commands, she was mute. She had gegenhal-
ten in both arms and eyelids upon passive manipulation. She
had no motor weakness. Other catatonic features included a
protruding grimace (schnauzkrampf), bilateral grasp reflexes,
and mitgehen in the right arm.
Differential considerations included a worsening of her
parkinsonian ‘‘off’’ state versus catatonia. Lorazepam 2 mg
was given intravenously. Her Bush-Francis catatonia rating
scale3 score was 24 prior to the injection and decreased to 10
after 4 min. Rigidity decreased and her grimace and mitge-
hen disappeared. She spoke a few words softly and followed
simple commands. These symptoms remained unchanged as
the left DBS electrode was placed.
Postoperative noncontrast head CT (see Fig. 1) revealed
an acute intraparenchymal hematoma in the right frontal lobe
measuring 7.0 cm by 2.8 cm. There was a small amount of
associated extra-axial blood. There was mild adjacent mass
effect with effacement of the cerebral sulci and frontal horn
of the right lateral ventricle with subfalcine herniation and
associated mild midline shift to the left.
She was transferred to neurosurgical intensive care where
her Bush-Francis score 4 hours after surgery was 28. Her fea-
tures of stupor, rigidity, negativism, grimacing, and mitgehen
had returned. She was managed supportively for 10 days
without change in her examination. A trial of high dose lora-
zepam or electroconvulsive therapy (ECT) was not pursued.
She was then transferred to a subacute care facility closer to
home where her subsequent course is unknown.
We know of no other cases of catatonia associated with
DBS surgery or treatment. In the intraoperative setting, the
main differential consideration was whether her exam repre-
sented a worsening of her parkinsonian ‘‘off’’ state. Her ri-
gidity and paucity of spontaneous movements were consistent
with this diagnosis. However, the mutism, negativism, gegen-
halten, and grimacing were inconsistent with previous ‘‘off’’
examinations. The positive lorazepam challenge supported
the diagnosis of catatonia.
We cannot infer a specific mechanism for the development
of catatonia in our patient. Although the frontal lobe hemor-
rhage is an obvious etiologic candidate, there may have been
contributions from multiple factors, including the direct sur-
gical manipulations of basal ganglia regions and the patient’s
demographic predisposition to catatonia. Despite her history
of PD and mood disorder, she had never been catatonic prior
FIG. 1. Postoperative three dimensionally reconstructed image (left)
and noncontrast head CT (right). [Color figure can be viewed in the
online issue, which is available at www.interscience.wiley.com.]
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to DBS surgery. There are a number of reports of catatonia
secondary to infarct or hemorrhage.4 Gelenberg reported a
case of catatonia following bilateral surgical lesions of the
globus pallidus to relieve symptoms of PD.5 Catatonia has
also been reported following surgical removal of lesions near
the pallidum, hypothalamus,6 and cerebellum.7
As the field of DBS grows to include treating mood disor-
ders—the leading cause of catatonia—the teams caring for
patients should be familiar with this increasingly recognized
syndrome and consider including formal assessments for cat-
atonia part of routine care.
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Sleep Apnea Associated With Floppy
Epiglottis in Adult-Onset Alexander Disease:
A Case report
Alexander disease is a rare leukoencephalopathy, caused
by dominant mutations in the gene encoding glial fibrillary
acidic protein (GFAP).1 A recent study reported that patients
with adult-onset Alexander disease might develop sleep-dis-
ordered breathing (SDB), a condition characterized by
repeated episodes of apnea and hypopnea during sleep,2
although the mechanism of airway obstruction in this disease
has not been clarified. Here we report a patient with adult-
onset Alexander disease presenting with SDB associated with
floppy epiglottis.
A 40-year-old man with a 10 year history of slowly pro-
gressive ataxic gait was admitted to our hospital because of
nocturnal inspiratory stridor. He was diagnosed having adult-
onset Alexander disease on the basis of DNA analysis of the
GFAP gene, which revealed a heterozygous substitution of T
for C at nucleotide 302, leading to conversion of Leu 101 to
Pro, as reported previously.3 Examination on admission
revealed that his height, weight, and body mass index were
169.5 cm, 69.5 kg, and 24.2, respectively. Neurological ex-
amination revealed truncal and limb ataxia, dysphagia, dys-
arthria, spastic weakness, palatal myoclonus, urinary inconti-
nence, and mild cognitive impairment. His only medication
was urapidil (30 mg daily) for his neurogenic bladder.
The patient also presented with inspiratory stridor during
sleep. His Epworth sleepiness score (ESS) was nine (<10:
normal). Polysomnography, performed according to the rec-
ommendations of the American Academy of Sleep Medicine
(AASM) Task Force in 1999,4 revealed severe SDB (apnea
index, 67.0/h; apnea–hypopnea index, 67.1/h; maximal apnea
duration, 67 s; and arousal index, 34.3/h). Of the 479 apneic
episodes, 53.0% were obstructive, 37.8% were mixed, and
9.2% were central. Although the saturation during the awake
status was 96 to 97%, oxygen desaturation was severe
(%sleep time with SpO2 below 90%, 58.6%; mean oxygen
saturation, 89.0%; and minimal oxygen saturation, 75%). His
desaturation was observed regardless of the sleep stage,
although oxygen saturation was comparatively lower during
non-REM stages (SpO2 5 85%) than during REM stage
(SpO2 5 89%). Frequency of rapid eye movement (REM)
sleep were normal (%stage REM 5 21%), and latency of
REM sleep were slightly short for his age (REM latency 5
66 minutes).
Fiberoptic laryngoscopy during wakefulness revealed no
apparent sites of upper airway obstruction, but under propo-
fol-induced anesthesia5 it revealed that the epiglottis was
sucked into the glottis during inspiration (Fig. 1). To deter-
mine whether continuous positive airway pressure (CPAP)
treatment can improve SDB associated with floppy epiglottis,
we examined the effect of the treatment on airway obstruc-
tion and oxygen saturation. We found that positive pressure
>6 cm H2O exacerbated upper airway obstruction by further
promoting the downward displacement of the epiglottis into
the laryngeal inlet. In addition, CPAP treatment >10 cm
H2O worsened oxygen desaturation from 94 to 86%. We
decided to abandon treatment using CPAP or noninvasive
positive pressure ventilation (NPPV), because there was a
possibility that positive pressure ventilation might cause wor-
sening of upper airway obstruction. Instead, we proposed
treating the patient’s SDB with tracheostomy; however, he
did not choose tracheostomy but wanted to continue rehabili-
tation for his dysphagia.
In this report, we present several novel findings in the
patient with SDB and adult-onset Alexander disease. First,
patients with this disease can develop inspiratory stridor
and obstructive sleep apnea associated with floppy epiglot-
tis. Floppy epiglottis is a condition in which the epiglottis
is sucked into the glottis during inspiration and is a com-
mon cause of laryngeal stridor in infants, which is caused
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by a congenital abnormality in laryngeal cartilage.6
Although floppy epiglottis of adult onset is a very rare
condition, it has been reported in patients after a head
injury7 or a cerebrovascular accident.8 We recently reported
that patients with multiple system atrophy develop floppy
epiglottis, which causes inspiratory nocturnal stridor and
obstructive sleep apnea.5 Because it has been speculated
that floppy epiglottis is caused by the loss of laryngeal
motor tone associated with the degeneration of the nucleus
ambiguus,9 floppy epiglottis in the present patient might be
related to brainstem lesions associated with Alexander disease.
Second, this study reported that patients with adult-onset
Alexander disease can develop sleep apnea of central origin,
though central apnea was not frequent (9.2%). Future studies
should be performed to investigate whether adult-onset
Alexander disease can develop central apnea, because
patients with this disease have prominent atrophy of the
lower brainstem, where the respiratory center is located. When
patients with adult-onset Alexander disease develop SDB, it is
important to determine the mechanism of sleep apnea.
Finally, we show that CPAP treatment can exacerbate
floppy epiglottis-associated SDB. In addition, a recent study
showed that CPAP treatment exacerbated the airway patency
of congenital floppy epiglottis.10 It is important to note that
CPAP treatment can exacerbate SDB in patients with floppy
epiglottis.
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Propriospinal Myoclonus Due to Cord
Compression in the Absence of Myelopathy
Video
A 43-year-old woman presented with 3 year history of
involuntary rapid flexion of the trunk and proximal legs,
inconsistently preceded by a sensation of tightness in the pos-
terior thigh muscles. These myoclonic jerks could only be
suppressed for a few seconds and they could be triggered by
sensory stimulation (such as rubbing her back). The move-
ments were exacerbated by prolonged standing and by flexion
or rotation of her neck. She worked in a bakery, where nega-
tive myoclonus (asterixis) of the legs would cause her to
stumble while carrying trays of baked goods. For one year
before the onset of myoclonus, she had been experiencing a
burning discomfort in both thighs after prolonged sitting.
These symptoms were ameliorated by ropinirole 2 mg QHS,
but this was discontinued as the myoclonus became the pre-
dominant source of disability. Myoclonus did not improve
with valproic acid, clonazepam, or levetiracetam despite slow
titration to doses sufficient to cause side effects. There was
no family history of myoclonus or dystonia. She denied leg
weakness or numbness, bowel, bladder, or sexual dysfunc-
tion. Examination showed spontaneous and stimulus-sensitive
axial and appendicular myoclonus (see Video Segment 1).
There was a right crossed adductor response. All laboratory
tests, including complete blood count, human T-cell lympho-
trophic virus I and II antibodies, antitransglutaminase immu-
noglobulins, and iron studies, were normal. Somatosensory
evoked potentials had normal amplitudes and latencies.
EEG with back-averaging did not show any cortical onset
of the myoclonus. MRI of the brain was normal. MRI of
the cervical spine (Fig. 1) showed a herniated interverte-
bral disc at C5 to six contacting the anterior spinal cord
without cord deformity or signal change. After consultation
with three separate spine surgeons, the patient underwent
anterior cervical discectomy with fusion. Postoperatively
there was initial exacerbation of the myoclonus for the first
2 weeks. The myoclonus gradually improved over the
ensuing 2 months, and virtually resolved once the cervical
collar was removed (see Video Segment 2). Less than once
per day, a single jerk does still occur. The patient experi-
enced benefit for persistent restless legs symptoms after
having resumed ropinirole.
DISCUSSION
Propriospinal myoclonus involves a shock-like flexion of
the trunk or proximal extremities due to caudal and rostral
conduction along propriospinal pathways from a spinal cord
generator site.1 The movements can be triggered by external
stimulation, such as tapping of bicep or patellar tendons, but
not by startle. Various premonitory sensations were reported
by 6 of 10 subjects in a recent case series of propriospinal
myoclonus.2 Electromyography can be useful to support a di-
agnosis of propriospinal myoclonus3 and might have been
helpful in our case. We were able to exclude psychogenic
myoclonus or myoclonic tics by demonstrating the absence
of event-related cortical potentials during EEG. A spinal cord
origin was implicated by the asymmetric reflexes and MRI
findings.
Resolution of spinal segmental myoclonus4 or propriospi-
nal myoclonus5 after surgery for associated radiculopathy has
been previously reported. We suggest that radiculopathy or,
as in our patient, compression or vascular embarrassment of
motor tracts in the spinal cord, can lead to myoclonus by dis-
rupting afferent signals originating distal to propriospinal
pathways. Disruption of this afferent information would be
expected to disrupt inhibitory motor loops. Our case demon-
strates that propriospinal myoclonus can be caused by com-
pressive spinal cord lesions even in the absence of other
signs of myelopathy and can be relieved by decompressive
surgery.
LEGENDS TO THE VIDEO
Segment 1. Patient had stimulus-sensitive axial and appen-
dicular myoclonus while seated, and asterixis of proximal
lower extremities with weight bearing.
Segment 2. Myoclonus virtually resolved after cervical
spine surgery.
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Chorea in Adults Following Pulmonary
Endarterectomy
Video
Pulmonary endarterectomy (PEA) is performed in patients
with chronic thromboembolic pulmonary hypertension with
surgically accessible thrombi.1 In our hospital, 5 patients
developed chorea in the post operative phase. We have previ-
ously reported on the occurrence of chorea following PEA
with deep hypothermia and circulatory arrest in a smaller
patient population.2 The aim of this article is to present the
patient’s videos and to discuss the probable pathogenesis of
chorea in adults.
Five out of 106 consecutive adult patients who underwent
PEA in our hospital developed chorea. Nine patients died
during or shortly after surgery without having regained con-
sciousness and were excluded from the analysis. PEA was
performed as previously reported.3
The records of all patients were assessed for surgical char-
acteristics. The data of patients with chorea (n 5 5; 3
women; age 45.5 6 SD 12.3 years) were compared with the
data of patients without chorea (n 5 92; 57 women; 54.7 6
13.9 years) using Mann-Whitney U test.
In chorea patients, the total circulation arrest time was lon-
ger (63 minutes 6 9 vs. 44 minutes 6 17; P < 0.01), and
they were rewarmed quicker (0.188C/minutes 6 0.03 vs.
0.148C/minutes 6 0.02; P < 0.0001; see Fig. 1) as compared
to nonchorea patients. Mean bypass time was longer in cho-
rea patients as compared to nonchorea patients (137 minutes
FIG. 1. C-Spine MRI shows C5 to 6 posterior disc bulge with minimal narrowing of the spinal canal.
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6 26 vs. 110 minutes 6 29; P < 0.05). Moreover, the cho-
rea patients were offered higher absolute temperatures
(37.88C 6 0.5 vs. 36.98C 6 0.7; P 5 0.002) during rewarm-
ing. There was no difference between patients who developed
chorea and those without chorea regarding age, gender, total
time on pump, speed of cooling, highest temperature reached,
and reperfusion time. All chorea patients underwent formal
neuropsychological testing and when possible MRI of the
brain (Table 1). The choreatic movements started 3 to 7 days
after surgery and gradually faded.
Chorea is well known in children4,5 and seems to be asso-
ciated with prolonged time on pump, duration of circulatory
arrest time, deep hypothermia, and hypoxia.6–8 The course of
chorea in children appears similar to what we have observed;
chorea starting 3 to 7 days postoperatively, gradually fading,
and disappearing in the following weeks to months.9–11
Deep hypothermic circulatory arrest impairs the recovery
of both cerebral blood flow (CBF) and cerebral metabolism
proportional to the duration of the arrest.12–14 In an animal
model, however, rapid rewarming after hypothermia during
cardiopulmonary bypass surgery causes an increase in the
cerebral metabolic rate for oxygen that is temporarily
unmatched by CBF.15 The slower recovery of CBF—as com-
pared to metabolism—may be explained by the following
phenomena: cerebral micro vessels have an initial contractile
response to acute increase in temperature16; hypothermic cer-
ebral micro vessels are less responsive to vasodilatory stim-
uli17; and the production of brain vasodilatory substances is
determined by brain temperature rather than cerebral metabo-
lism.18 We hypothesize that the chorea in our patients might
be a sequela of brain lesions caused by a mismatch between
CBF and brain metabolism induced by faster rewarming. In
addition, the longer circulation arrests might have aggravated
slower recovery of CBF.
Diffusion weighted imaging in patient D showed bilateral
lesions of the globus pallidus. In children with postpump
chorea, neuropathological abnormalities involving the exter-
nal globus pallidus and the pallidosubthalamic pathway have
been reported.19,20 The globus pallidus and striatum are sus-
ceptible for hypoxemia, probably due to differential cellular
responses to deprivation of energy substrates and sustained
activation of glutamate receptors.21
In conclusion, chorea in adults following deep hypother-
mia with cardiac arrest appears to be related to lengthy circu-
lation arrest and faster rewarming. Although initially the cho-
rea may be incapacitating, the course is rather benign. Clini-
cians should avoid quick rewarming following hypothermia
and if possible shorten the circulation arrest period.
FIG. 1. Scatter plot of total circulatory arrest time versus speed of rewarming. The filled dots indicate patients with chorea (n 5 5) and the open
dots patients without chorea (n 5 92). The scatter plot shows that patients with chorea had a relatively longer circulatory arrest and were
rewarmed faster.
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Transient Chorea Following PEA
Segment 1. The first segment shows patient A 5 days and
15 days after surgery. Five days after surgery, she has a
delayed initiation of voluntary actions. When asked a ques-
tion, there is a delay in answering. When asked to look in a
particular direction, there is delayed saccade initiation, and
she breaks fixation by blinking (oculomotor apraxia). At the
same time, she has chorea-ballism, dystonia, and motor
impersistence. In the video, she is asked to take a hand, but
she is unable to initiate the movement. She confirms this
when asked about it. There is no weakness. Fifteen days after
surgery, the chorea has disappeared, though she still seems
fidgety.
Segment 2. The second segment shows patient B 4 days,
7 days, 14 days, and 2 months after surgery. Four days after
surgery, she has a delayed initiation of voluntary actions.
When asked to lift her arms she is unable to initiate the
maneuvers. The patient has chorea-ballism, dystonia, and
motor impersistence. The video-parts regarding day 7, day
14, and 2 months after surgery show the gradual decline of
the chorea.
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TABLE 1. Results of neuropsychological testing and brain imaging of the patients with chorea
Neuropsychological testing Brain imaging Choreatic Symptoms
A Day 12; Disinhibition and
mild slowness in retrieval
of verbal information, no
attention deficit
Day 6; MRI showing no
abnormalities
She felt as if intoxicated 2 days after PEA and chorea slowly developed. 3
days after PEA she developed generalized chorea with severe dystonia
and oculogyric crises (video), hardly noticeable at rest. She could not
perform tasks and had difficulty with speaking. The involuntary
movements gradually disappeared 4 weeks later. Seven years after PEA,
she has no complaints.
B Day 11; Short-term memory
impairment, impaired
allocation of attention,
instability of emotion, and
mood disturbances
Day 11; MRI difficult to
interpret due to movement
artifacts, but no gross
abnormalities
She had severe incapacitating generalized chorea with dystonia and
oculogyric crises 24 hours after PEA, which was almost absent at rest
(video). She could not sit without help. The involuntary movements
gradually diminished over the following two months. Six years later she
continues to have minor choreatic movements when tired or stressed. She
experiences no limitations.
C Day 3; she scored 22 out of
30 on the Mini Mental
State Exam,22 missing 4
points on serial
subtraction of 7. No
formal neuropsychological
examination performed.
Not performed She displayed dysarthria, ataxia, and mild generalized chorea 3 days after
PEA. Next day, the ataxia and chorea were gone. Dysarthria and
emotional instability gradually improved over the following days. One
week later, she had no neurological symptoms and signs. Seven years
later she has no complaints.




Day 8 and day 12; MRI showed
bilateral hyperintense lesions
of the globus pallidus on
diffusion weighted imaging
He displayed chorea, dystonia, and oculogyric crises 2 days after PEA. The
severe involuntary movements were treated with 5mg haloperidol 3dd1,
resulting in gradual fading of the involuntary movements 1 week later.
He showed mild generalized chorea till his death three years later, due to
a colon carcinoma.Day 15: IBZM-SPECT scan
showed decreased post-
synaptic D2-receptor binding






Day 14: MRI multiple small
hyperintense white matter
lesions on Flair
He gradually developed chorea 3 days after PEA, which subsided 10 days
later. He claimed a lot of attention and was vocally-disinhibited. In 3
weeks time, the behavioural side effects gradually disappeared. He did
not display any eye movement abnormalities. 2 years later he has no
complaints.
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Cerebellar Involvement in Progressive
Supranuclear Palsy
Among 22 Japanese patients with pathologically proven
progressive supranuclear palsy (PSP),1 3 patients with unclas-
sified PSP presented with cerebellar ataxia as the initial/prin-
cipal clinical symptom and had more frequent tau-positive
inclusions in the Purkinje cells of cerebellar cortex and more
severe involvement of the cerebellar dentate nucleus than
other cases. This suggests that ‘‘PSP with cerebellar ataxia’’
is a clinical subtype of PSP. The clinical and pathologic het-
erogeneity of PSP2,3 is illustrated by a personal series of 30
autopsy-proven cases of PSP from Vienna, Austria [18
Richardson syndrome (RS) and 12 PSP-Parkinsonism (PSP-
P)]. In none of these patients was cerebellar ataxia reported
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as the initial or principal symptom, whereas two of them
(6.7%) developed cerebellar signs in late stages of the dis-
ease. This is similar to the frequency in other series.4 As in
the majority of autopsy series of PSP,2,5 the cerebellar den-
tate nucleus showed considerable involvement, which was
more severe in RS than in PSP-P cases,3,6,7 whereas in six
cases (20%) it was spared. Tau deposits in Purkinje cells
were seen in only the two brains from RS cases that had
developed late cerebellar signs. As in most Western clinico-
pathologic PSP series, no case of ‘‘unclassified PSP’’ with
cerebellar involvement was observed in our series, which
may, at least in part, be related to ethnic and genetic reasons.
Kurt Jellinger, MD*
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Shoulder Pain in Parkinson’s Disease:
A Case-Control Study
Although pain symptoms related to Parkinson’s disease
(PD) are described in the literature, an increased risk of
shoulder pain in PD compared with a control population
has not been established. This study was designed to better
define the association between PD and shoulder pain con-
trolling for potential confounders. We hypothesized that
shoulder pain is more prevalent in PD patients compared
with controls.
A cross-sectional and retrospective study was conducted
with PD subjects and normal controls. Subjects were diag-
nosed with idiopathic PD on the basis of Gelb criteria and
the Hoehn and Yahr scale was determined by a movement
disorder specialist.1,2 We recruited consecutive patients being
seen for routine care in our Movement Disorder clinic, and
spouses served as controls. Subjects were asked whether they
had shoulder pain, to characterize shoulder pain, if present,
and to answer questions related to PD onset, symptoms,
medication use, and history of prior injury. Subjects also
completed a visual analog scale to assess the severity of
pain. Descriptive statistics were used for demographic infor-
mation. The data was analyzed using multivariate logistic
regression, with pain as the outcome variable; and age, gen-
der, Hoehn and Yahr, and history of previous injury as model
covariates with statistical significance at P 5 0.05. The insti-
tutional review board approved this study and all subjects
signed informed consent.
A total of 25 PD patients and 25 controls were recruited.
The average age (mean 6 standard deviation) of the cases
was 65.3 6 12.3 and of controls was 64.6 6 11.9. Forty-
eight percent of cases were male and 56% of controls were
male. Average Hoehn and Yahr stage of cases was 2.2
(standard deviation of 60.61). In the PD group, 80% of sub-
jects had pain compared with 40% in the control group. Most
of the PD patients described the shoulder pain as dull and
aching, with 80% of them experiencing pain in both should-
ers, compared with 20% in controls. The pain rating scale in
the PD cases ranged from 4/10 to 10/10, when the pain was
at its worst. The multivariate regression (Table 1) showed
that PD patients have six times the odds of having shoulder
pain compared with those without PD. When adjusted for
age, gender, and prior injury; PD patients have 21 times the
odds of having shoulder pain compared with those without
PD. There were no PD cases reporting prior shoulder injury
whereas this confounder occurred in many of the controls.
There was no association between Hoehn and Yahr stage and
presence of pain. In the PD group, 40% reported that PD
treatment improved the shoulder pain, 40% reported it was
not effective, and 20% were uncertain. The PD treatments
reported to help were dopaminergic medications, including
carbidopa/levodopa, pramipexole, ropinirole; and deep brain
stimulation surgery.
There are several potential explanations for the strong
association between shoulder pain and PD. Prior injury has
been hypothesized to be related to shoulder pain in PD, but,
none of our PD subjects reported previous shoulder injury
compared with 70% of the controls. Muscle cramps and
tightness occurs in most PD patients3 and the increase in
shoulder pain may be related to the rigidity seen in PD.
However, in this study the majority of PD subjects suffered
from bilateral shoulder pain, despite asymmetry of rigidity on
exam. Finally, controls may not have been representative of
the general population.
Studies have shown that 30–40% of PD patients complain
of pain,4,5 which was consistent with our results. A recent
study found that PD patients have a lower heat pain threshold
compared with controls, with the authors hypothesizing that
basal ganglia abnormalities may alter pain coding.6 Addition-
ally, PET scans have shown that striatal D2 receptors are
involved in central pain pathways and that a decrease in D2
receptors results in an increase in pain perception.7 These
studies may suggest that pain in PD is related to the underly-
ing pathophysiology of PD rather than motor signs. We did
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not specifically examine whether shoulder pain preceded the
original diagnosis of PD and whether shoulder immobility
may be a very early potential sign of incipient PD. With the
search for preclinical features for neuroprotection and the in-
terest in the overlap between motor and nonmotor features of
PD, a detailed study to better define this association in
regards to shoulder pain may lead to practical application of
these results.
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Is It a Tic?—Twenty Seconds to
Make a Diagnosis
Tics are often classified as a movement disorder. However,
their movement kinematics are indistinguishable from normal
movements.1 Also, tics are sometimes preceded by premotor
potentials typically present before self-paced voluntary move-
ments2 albeit this is not always the case.3 Thus, rather than
abnormal movements, tics may be better defined as fluctuat-
ing ‘‘prewired bits of behavior’’ misplaced in both context
and time.4 This implies that it may be difficult to identify a
tic in isolation but easier on the basis of its occurrence in
time. Therefore, either short (3 seconds) or longer (20 sec-
onds) video clips showing tics of Gilles de la Tourette (GTS)
patients or clips showing spontaneous movements of healthy
controls were presented to GTS experts with the instruction
to decide whether presented movements were tics or not.
Videos of 12 GTS patients (11 men, mean age: 43.1 6
12.2 years) assessed by MO and MMR were available. GTS
was diagnosed according to DSM-IV-TR criteria.5 Twelve
age and sex matched healthy controls (11 men, mean age: 39
6 13.3 years) were also filmed. Participants gave informed
written consent granting permission for the videos to be used
for research purposes.
Video clips were cut from video recordings taken accord-
ing to the GTS Rush Video protocol6 from GTS patients and
a standardized video recording from healthy controls with the
instruction to wait and to behave normally. Twenty-four
tic videos and 24 video sequences from healthy controls
showing a spontaneous movement lasting no more than
3 seconds were created from head and shoulder view
segments (Table 1).
Another 48 video sequences (24 clips showing GTS
patients and 24 clips showing healthy controls) with a dura-
tion of 20 seconds were cut from the same video material.
Two-blinded GTS experts were asked to review the clips and
decide whether the movements were tics or spontaneous
movements. First, the 3 second and, after an interval of at
least 1 week, the 20-second sequences (with the experts
unaware of the 3-second clip rating results) were reviewed.
Frequency of movements in 3-second clips did not differ
between groups in any category (Binomial-Tests). In 20-sec-
ond clips, patients’ tic videos showed significantly more tics
[mean of 17 (SD 9.4)] than healthy control videos spontane-
ous movements [mean of 6 (SD 3.4); df 5 1, Z 5 2.309, P
< 0.001; Kolmogorov-Smirnov test; Table 1]. Also, patients’
TABLE 1. Analysis of shoulder pain adjusted for age, gender, and previous injury
Variable Cases % (n) Control % (n) OR 95% CI P value
Shoulder pain 80 (20) 40 (10) 6 1.69–21.6 0.006
Adjusted for age and gender 6 1.69–21.3 0.006
Adjusted for previous injury 0 (0) 70 (19) 21.63 4.25–110 0.0002
OR, odds ratio.
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tic clips showed significantly more mouth (df 5 1, Z 5
2.107, P < 0.001) and whole head tics (df 5 1, Z 5 1.656,
P 5 0.009) than respective movements in healthy controls
(Table 1).
Regarding 3-second video clips, expert I categorized 46%
videos correctly, and expert II 81% (Inter-rater reliability
(IR)—0.59; Cronbach’s Alpha). Expert I rated 11 of the 48
short clips incorrectly as showing tics and 14 incorrectly as
showing spontaneous movements. Expert II misclassified two
videos of spontaneous movements as showing tics and seven
tic videos as showing spontaneous movements.
Twenty-second video sequences were classified correctly in
73% by expert I and 96% by expert II (IR 0.71). Expert I incor-
rectly classified two videos showing spontaneous movements
as tics and 11 videos showing tics as spontaneous movements.
Expert II misclassified two tic videos as spontaneous move-
ment videos. Except for one video, all misclassified videos of
rater II were also incorrectly rated by rater I. Diagnostic accu-
racy was higher for 20-second clips compared to 3-second clips
in rater I (df 5 1, v 5 6.12, P 5 0.020; McNemar tests) but
not in rater II (df 5 1, v 5 1.3, P5 0.300).
The main finding is that it is more difficult to distinguish
a single tic from a single spontaneous movement than a se-
ries of tics from a number of spontaneous movements. Thus,
tics are probably best described as movements becoming
abnormal in time because they deviate from the movement
repertoire considered ‘‘normal.’’
Some tics involved certain anatomical regions/muscles
more frequently than spontaneous movements, e.g., mouth
and whole head tics, but these differences alone do not suf-
fice to explain why diagnostic certainty and inter-rater agree-
ment was so high after only 20 seconds. On 20-second vid-
eos GTS patients moved significantly more frequently than
healthy controls. This difference, i.e., the ‘‘too much’’ of
something normal, was probably the most distinctive element
allowing to correctly identify tics. We conclude that longer
video clips can capture the nature of tics as ‘‘excess’’ normal
movements and aid the diagnosis of a tic disorder.
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3-second clips 20-second clips
Controls GTS Controls GTS
Eyes 6 (25) 6 (25) 108 (77) 114 (28)
Eyebrow 3 (13) 4 (17) 1 (0.5) 48 (11)
Nose 2 (8) 2 (8) 3 (2) 27 (6)
Mouth 8 (33) 10 (42) 15 (11) 103 (25)**
Jaw – – – 15 (6)
Whole head 5 (21) 2 (8) 12 (8.5) 77 (18)*
Shoulder – – 2 (1) 27 (6)
Sum 24 24 141 411**
Numbers are absolute values (% in brackets) of movements/tics
shown on respective video clips.
*P < 0.05; **P < 0.01 (differences in the frequency of move-
ments occurring in the respective category for 20-second clips).
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